Patterns of emerging superbugs underscore the need for new technologies to reduce exposures to contaminants both on the combat field and in healthcare facilities here at home. New data presented from the University of Virginia at the Interscience Conference for Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago examines the efficacy of VTT-003 (Vestex) fluid barrier and antimicrobial impregnated fabric versus two bacteria strains that are resistant to many drugs. Drs. Amy Mathers and Gerald Donowitz from UVas Department of Infectious Diseases presented their research, Bactericidal Effect of Antimicrobial-Treated Textiles on Multi-drug Resistant Gram Negatives.
Â
Vestex was able to kill greater than 99.99 percent of our worst and most resistant gram negative organisms in our laboratory testing, says Mathers.
VTT-003, sold under the name Vestex, is the first in a new class of active barrier protective fabrics that are clinically proven to rapidly prevent, reduce or eliminate the acquisition and retention of contaminants on the durable, breathable fabric. We are proud of the rich and growing evidence base for the use of Vestex. Its a research-based solution to the problem of contaminated textiles in healthcare, says Ben Favret, president and CEO of Vestagen, makers of Vestex. This presentation marks the fifth research study documenting Vestex performance characteristics.Â
Mathers and Donowitz tested both the antimicrobial agent used in Vestex alone and the fluid barrier and antimicrobial-impregnated Vestex fabric for its ability to kill these multi- drug resistant bacteria. The data show that the antimicrobial- treated fabric demonstrated in vitro bactericidal activity against pan-resistant A. baumannii and multidrug-resistant K. pneumoniae. Further, they conclude that this could be of potential use in decreasing transmission of multi-drug resistant gram negatives in the healthcare setting.
Multidrug-resistant bacteria have become more prevalent in the combat field, in healthcare facilities and in communities here at home. Two recent studies in the American Journal of Infection Control characterized the bacteria as well as the high percentage of healthcare workers uniforms that become contaminated..
One study states that drug-resistant Acinetobacter baumannii-calcoaceticus complex, Klebsiella pneumoniae, and methicillin-resistant Staphylococcus aureus colonize and infect combat casualties from Iraq and Afghanistan. Colonizing organisms were unrelated to isolates producing later infection in up to 27 percent of cases; most isolates underwent changes in antibiotic susceptibilities.
The other study from a large Israeli hospital reports that 60 percent of healthcare workers uniforms harbored dangerous bacteria. Among the pathogens cultured from uniforms were Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus (MRSA.)
To learn more about Vestagens engineered medical uniforms, visit www.vestexprotects.com
. Â
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.